Sebastian Nijman

Sebastian Nijman

Company: Scenic Biotech

Job title: CSO

Seminars:

QPCTL is a Small Molecule Drug Target Modulating the Innate Imune Response 12:00 pm

Discovery and validation of QPCTL as a drug target; Drug discovery and development efforts at Scenic BiotechRead more

day: Discovery & Pre-Clinical Development - Day 1 am

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.